Method for Improved Selection of Therapeutic Agents
OwnerOleksandr Obodnikovinventor
Life of this patent
Estimating the term…
Abstract
The current invention comprises a method of selection of therapeutic agents for treatment of a particular disease in humans or other mammals in which the ratio of the concentrations of thiol (—SH) and disulfide (—SS—) groups is determined in the blood. The therapeutic agent to be tested may be used to treat a neoplastic, infectious, immunological, inflammatory, or other disorder that involves (but is not limited to) the following physiological systems: respiratory, cardiovascular, genitourinary, gastrointestinal (including the liver and pancreas), neurological, musculoskeletal, immunological, and skin.
Claims10
A method of selection of therapeutic agents for treatment of a particular disease in humans or other mammals in which the ratio of the concentrations of thiol (—SH) and disulfide (—SS—) groups (to be referred to as the thiol-disulfide ratio or TDR) is determined in the blood.
Dependencies are inferred from the claim text.